PTP4A2: A Promising Drug Target and Biomarker for neurodegenerative Disorders

Target Name: PTP4A2

NCBI ID: G8073

PTP4A2

PTP4A2: A Promising Drug Target and Biomarker for neurodegenerative Disorders

Introduction

Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells and their respective neurotransmitters, leading to the decline in cognitive and motor functions. These conditions are often treated with drugs that aim to slow down or halt the progression of neurodegeneration. However, current treatments are limited in their effectiveness and can have potential side effects. Therefore, there is a need for new drug targets and biomarkers to improve the treatment outcomes for neurodegenerative diseases.

PTP4A2: A Candidate Drug Target and Biomarker

The protein tyrosine phosphatase type IVA 2 (PTP4A2) is a potentially targetable protein that is involved in the regulation of neurotransmitter release and neurotransmission. It is a key enzyme in the phosphorylation cascade of tyrosine, which is critical for the regulation of neuronal excitability and synaptic plasticity. The dysfunction of PTP4A2 has been implicated in the development and progression of neurodegenerative diseases.

Expression and function of PTP4A2

PTP4A2 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is a member of the tyrosine phosphatase family 4 and is localized to the endoplasmic reticulum (ER) and the cytoplasm. PTP4A2 plays a crucial role in the regulation of neurotransmitter release and neurotransmission by phosphate orylation and dephosphorylation of tyrosine residues.

In neurotransmission, PTP4A2 is involved in the regulation of the release of neurotransmitters such as dopamine, nitric oxide, and GABA. It has been shown that the levels of these neurotransmitters are affected by PTP4A2, and that dysfunction in PTP4A2 has consequences on neurotransmission. For instance, PTP4A2 has been shown to play a role in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt over time.

In addition to its role in neurotransmission, PTP4A2 is also involved in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell survival and proliferation by promoting the phosphorylation and subsequent ubiquitination of the negative regulator, p53.

Dysfunction of PTP4A2 in neurodegenerative diseases

The dysfunction of PTP4A2 has been implicated in the development and progression of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In Alzheimer's disease, PTP4A2 has been shown to be involved in the regulation of neurotransmission and neurotransmission-related protein synthesis, and to play a role in the development of neurofibrillary tangles and neuroinclusions.

In Parkinson's disease, PTP4A2 has been shown to be involved in the regulation of neurotransmission and neurotransmission-related protein synthesis, and to contribute to the development of the Lewy bodies, which are the hallmark pathological hallmarks of Parkinson's disease.

In Huntington's disease, PTP4A2 has been shown to be involved in the regulation of neurotransmission and neurotransmission-related protein synthesis, and to play a role in the development of the neurofibrillary tangles and the Huntington's disease protein.

Molecular mechanisms of PTP4A2 dysfunction in neurodegenerative diseases

The dysfunction of PTP4A2 in neurodegenerative diseases is thought to be caused by various factors, including genetic, cellular, and environmental factors.

Genetic factors, such as mutations in the PTP4A2 gene, have

Protein Name: Protein Tyrosine Phosphatase 4A2

Functions: Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. Promotes tumors. Inhibits geranylgeranyl transferase type II activity by blocking the association between RABGGTA and RABGGTB

The "PTP4A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTP4A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets